Skip to content

Clinical trials

Phase 3 COVID-19 trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Phase 3 Country / region: Brazil Clear all

69 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
202024
202127
202211
20232
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Unknown status12
Terminated12
Recruiting5
Withdrawn3
Suspended2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hospital Israelita Albert Einstein4
Applied Biology, Inc.3
BioNTech SE3
D'Or Institute for Research and Education3
AstraZeneca2
Cardresearch2
Eli Lilly and Company2
Gilead Sciences2
HRH Pharmaceuticals Limited2
Merck Sharp & Dohme LLC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1969
Coronavirus Infections15
Severe Acute Respiratory Syndrome8
Pneumonia7
Pneumonia, Viral6
Respiratory Tract Infections5
Virus Diseases4
Cytokine Release Syndrome3
Infections3
Lung Diseases3

Trials

Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.